Clinicopathological Characteristics and Treatment Outcomes of Patients with Advanced SMARCA4-Deficient Non-Small Cell Lung Cancer

被引：0
|
作者：
Liu, H. [1 ]
Hong, Q. [1 ]
Cai, L. [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
SD-NSCLC; ICIs; local treatment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14A.01
引用
收藏
页码：S271 / S272
页数：2
相关论文
共 50 条
  • [21] SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics
    Al-Shbool, Ghassan
    Nair, Hari Krishnan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [22] Molecular Characteristics of SMARCA4 Mutations Detection in Chinese Non-Small Cell Lung Cancer Patients
    Chen, X.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, Y.
    Chen, G.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1945 - S1945
  • [23] Clinicopathological Characteristics of Non-Small Cell Lung Cancer patients in the United Arab Emirates and Correlation with Their Outcomes
    Azribi, F.
    Yousif, A.
    Ansari, J.
    Dawoud, E.
    Trad, D.
    Al Qawasmeh, K.
    Al-Awadhi, A.
    Kurban, L.
    Hourani, M.
    Ahmed, M.
    El-Koha, O.
    Magdub, S.
    Elkkari, A.
    Al Baloushi, M.
    Black, E.
    Bennini, N.
    Balaraj, K.
    Gargoum, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S241 - S242
  • [24] Clinicopathologic characteristics and immunotherapy outcomes in SMARCA4-mutant (mut) non-small cell lung cancer (NSCLC).
    Alessi, Joao Victor Machado
    Glass, Carolyn
    Ricciuti, Biagio
    Spurr, Liam F.
    Sholl, Lynette M.
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis
    Bridges, John F. P.
    Mohamed, Ateesha F.
    Finnern, Henrik W.
    Woehl, Anette
    Hauber, A. Brett
    LUNG CANCER, 2012, 77 (01) : 224 - 231
  • [26] CRIZOTINIB FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A. J.
    Doebele, R. C.
    Camidge, D. R.
    Jimeno, A.
    DRUGS OF TODAY, 2012, 48 (04) : 271 - 282
  • [27] Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors
    Luo, Jizhuang
    Ding, Bowen
    Campisi, Alessio
    Chen, Tangbing
    Teng, Haohua
    Ji, Chunyu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4455 - 4463
  • [28] Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors
    Jizhuang Luo
    Bowen Ding
    Alessio Campisi
    Tangbing Chen
    Haohua Teng
    Chunyu Ji
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4455 - 4463
  • [29] The treatment of advanced non-small cell lung cancer
    Spiro, SG
    Silvestri, GA
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 287 - 291
  • [30] Treatment of advanced non-small cell lung cancer
    De Petris, L
    Crinò, L
    Scagliotti, GV
    Gridelli, C
    Galetta, D
    Metro, G
    Novello, S
    Maione, P
    Colucci, G
    de Marinis, F
    ANNALS OF ONCOLOGY, 2006, 17 : 36 - 41
12345